ライフサイエンスコーパス: crystal violet

1 les with volumes as large as 461 A(3) (e.g., crystal violet).

2 order of 10(11) of the signal detected from crystal violet.

3 nce was assessed by visual experiments using crystal violet.

4 Adherent cells were quantified using crystal violet.

5 95% relative to the energy transfer to free crystal violet.

6 le salt deoxycholate and the hydrophobic dye crystal violet.

7 ng likewise was decreased in the presence of crystal violet.

8 , the reproducibility SD (S(R)) was 0.44 for crystal violet, 0.53 for resazurin, and 0.92 for the pla

9 ch was verified using a low concentration of crystal violet (10(-)(5)M) as the probe molecule.

10 ur chromophores were examined: Rhodamine 6G, crystal violet, a cyanine dye, and a cationic donor-acce

11 t of energy transfer donors to the acceptor, crystal violet, a noncompetitive antagonist of the nAChR

12 Degradation efficiency of crystal violet and commassie blue R250 after 6 h was ass

13 iocin, and dyes such as ethidium bromide and crystal violet and increased accumulation of radioactive

14 and metabolic activity were quantified with crystal violet and methyl thiazolyl tetrazolium staining

15 It is concluded that crystal violet and other dyes of similar structure bind

16 e limit of detection for chemical sensing of Crystal Violet and Rhodamine 6G by the Al-QS was driven

17 Organic dyes such as crystal violet and Rhodamine B, the nucleobase cytosine,

18 Viability tests were performed with crystal violet and ROS tests with DCFH-DA.

19 Because of their optical properties, crystal violet and several of the other homologous dyes

20 istance to several antimicrobials, including crystal violet and streptomycin (this phenotype could al

21 ta sets {the reduction of chloranil by leuco crystal violet and the reduction of morphinone reductase

22 ith attached P. gingivalis were stained with crystal violet, and attachment was expressed based on dy

23 hree-dye mixture composed of methylene blue, crystal violet, and rhodamine 6G for positive ion mode d

24 The Raman spectroscopic studies using crystal violet as a reference sample show a limit of det

25 ssembly techniques to fabricate a pattern of crystal violet as a standard reticle slide for assessing

26 e fluorescent NCIs ethidium, quinacrine, and crystal violet as well as [(3)H]thienylcyclohexylpiperid

27 age of different dye molecules (pyranine and crystal violet) as well as avidin through melittin induc

28 We used a crystal violet assay and confocal laser scanning microsc

29 st, determination of colony-forming units, a crystal violet assay, scanning electronic microscopy and

30 MDA-MB-468 cancer cells was assessed via the crystal violet assay.

31 pectively at 48 mM caffeine as determined by Crystal Violet assay.

32 Resazurin and crystal violet assays indicated that 8a decreases triple

33 ective inhibitors, estimated cell numbers by crystal violet assays, measured caspase activity by clea

34 tumor cell survival, as measured by MTT and crystal violet assays, regardless of IGF1 pre-treatment.

35 y of staphylococcal isolates was assessed by crystal violet assays.

36 ducts necessary for biofilm development in a crystal violet-based assay involving 24-well tissue cult

37 ation by these M. catarrhalis strains in the crystal violet-based assay.

38 ly 3,000 transposon insertion mutants in the crystal violet-based biofilm assay system yielded six mu

39 Crystal violet binding blocked agonist-induced 22Na ion

40 with 1-2 negative charges within 8 A of the crystal violet binding site.

41 Following crystal violet biofilm assays for single metal ion solut

42 e to measure binding, we determined that one crystal violet bound per receptor with a dissociation co

43 ize76.49% of methylene blue (MB) compared to crystal violet, brilliant green, malachite green, and az

44 The flux of the crystal violet cation across the membrane is simultaneou

45 In the presence of sbeta-CD, the crystal violet-containing buffer was blue and was deflec

46 In the absence of sbeta-CD, the crystal violet-containing buffer was reddish/purple and

47 The electrochemical properties of poly (crystal) violet/copper oxide nanoparticles modified carb

48 te, the nAChR conformational-sensitive probe crystal violet (CrV) was used.

49 the binding site location for the fluorophor crystal violet (CrV), a noncompetitive antagonist of the

50 s synthesized and characterized for cationic crystal violet (CV) adsorption.

51 eport a photobactericidal polymer containing crystal violet (CV) and thiolated gold nanocluster ([Au(

52 Using Rhodamine 6G (R6G) and crystal violet (CV) as probe molecules, the sensor demon

53 fects, as well as bactericidal activity with crystal violet (CV) coated polyurethane.

54 , while biofilm detachment was evaluated via crystal violet (CV) staining and scanning electron micro

55 ]arene (SC4) interacts with the aromatic dye crystal violet (CV) to form complexes with stoichiometri

56 ection for various analyte molecules such as crystal violet (CV), rhodamine 6G (R6G), and 5,5'-dithio

57 mpounds, N-methyl mesoporphyrin IX (NMM) and Crystal Violet (CV).

58 e and gram-negative strains by staining with crystal violet (CV).

59 shows that using a batch approach to remove crystal violet dye from synthetic wastewater is feasible

60 Lysine, peptides, crystal violet dye, and a biotin conjugate are found to

61 Anionic I3(-) reacts with cationic crystal violet dye, and the product is extracted into 1-

62 Brilliant green and crystal violet dyes were the molecular probes, and the e

63 change was triggered by hydration of the dye crystal violet encapsulated in silica, as interstitial f

64 henylmethane dyes (rose bengal, rhodamine B, crystal violet, ethyl violet, fast green fcf, and brilli

65 uick electrochemical platform based on poly (crystal violet) film and copper oxide nanoparticles for

66 relative sensitivities are malachite green > crystal violet > quinaldine red > ascorbate reduction >

67 ing and chemical imaging of the cationic dye crystal violet in inked lines on glass and for lipid dis

68 absorbance and fluorescence spectroscopy of crystal violet in order to elucidate the binding mechani

69 potentials by the bound acceptor fluorophore crystal violet, its binding site was first localized wit

70 res of the TFME platform, a customized leuco crystal violet LAMP assay is used for visual detection o

71 plification products are detected with leuco crystal violet (LCV) dye by eye without a need for instr

72 GCN), basic fuchsin leuconitrile (BFCN), and crystal violet leucomethyl (CVMe) and leucobenzyl (CVBn)

73 The photochemical reactions of crystal violet leuconitrile (CVCN) were investigated by

74 oxynaphthol blue, phenol red, calcein, leuco crystal violet, malachite green, and a fluorescent dye f

75 ough HPLC-SERS analyses of model dyes (e.g., crystal violet, malachite green, and rhodamine) and phar

76 nt of a medical grade silicone incorporating crystal violet, methylene blue and 2 nm gold nanoparticl

77 ive SERS by measuring the areal densities of crystal violet molecules embedded in an ultrathin spin-o

78 same tissues with metachromatic dyes such as crystal violet or with the cotton dye Congo red (particu

79 rowth and was more susceptible to killing by crystal violet, osmotic shock, and select carbapenem ant

80 adical anion of 2-chloranthraquinone and the crystal violet radical, which display improved resolutio

81 film formation in 96-well microtiter plates: crystal violet, resazurin, and plate counts.

82 The patterned crystal violet reticle was also used to diagnose issues

83 One dye with high affinity, crystal violet, revealed a greater than 200-fold fluores

84 y reduced the biofilm density as measured by crystal violet staining and the viable bacterial counts

85 d by using a microtiter plate assay with the crystal violet staining method, and the presence of the

86 y continuous passaging at a 1:3 split and by crystal violet staining of confluent dishes.

87 HMC adhered strongly (quantified using crystal violet staining) to collagen IV and collagen I (

88 ve, cell outgrowth ([3H]thymidine uptake and crystal violet staining) was also tested.

89 Crystal violet staining, acryflavin agglutination, and p

90 ree independent measures: Congo red binding, crystal violet staining, and confocal laser scanning mic

91 s were evaluated by fluorescence microscopy, crystal violet staining, and the MTS assay.

92 A crystal violet staining-based assay shows that tiny bact

93 l strains were identified and quantitated by crystal violet staining.

94 mal and distal tubular cells, as observed by crystal violet staining.

95 ngs from this new assay using an established crystal-violet staining assay for a subset of hydrolase

96 was further supplemented with vancomycin and crystal violet to produce two selective media, named MSN

97 are consistent with preferential binding of crystal violet to the desensitized conformation of the A

98 ollected and visualized with the addition of crystal violet to the separation buffer.

99 Cell proliferation was monitored by crystal violet uptake, and pericyte migration was assess

100 containing buffer was reddish/purple and the crystal violet was deflected cathodically in the chamber

101 Further, crystal violet was electropolymerized on the surface of

102 from a neutral Tb3+ -chelate to nAChR-bound crystal violet was reduced 95% relative to the energy tr

103 This result indicated that crystal violet was strongly shielded from solvent when b

104 r example, spectra of glucose, arginine, and crystal violet were obtained with no observed interferen

105 ic dye and its metabolite, crystal and leuco crystal violet, were extracted from spiked fish extracts

106 pigment, and to regulate binding to the dye crystal violet, whereas motility, flagellar secretion, a

107 exhibits excellent sensitivity for detecting crystal violet with a limit of detection (LOD) as low as